Back to results
US 2026/0265349 A1Published application
Nanobody for norovirus
AssigneeGriffith University
InventorGrant HANSMAN
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to the field of nanobodies, therapeutic agents, compositions and methods for the prevention, amelioration and treatment of noroviral infections.
Claims24
A single domain antibody that is directed against a P domain of a norovirus, wherein the single domain antibody binds to or interacts with one or more residues of a P2 subdomain thereof.
-10. (canceled)
-23. (canceled)
(canceled)
-29. (canceled)
Dependencies are inferred from the claim text.